Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: September 29, 2011
Event: Entry into a new material definitive agreement and termination of a prior credit facility.
Key Financial Metrics
This filing reports on a specific financing transaction rather than periodic operating results. Consequently, revenue, profit, cash flow, margins, and liquidity metrics are not provided in this document.
- New Credit Facility: $1.5 billion Five Year Competitive Advance and Revolving Credit Facility.
- Terminated Facility: $2.0 billion Five Year Competitive Advance and Revolving Credit Facility (established December 2006).
- Financial Covenants: None.
- Rating Requirement: Must maintain a long-term debt rating from a certain credit rating agency.
Material Changes Versus Prior Period
The Company replaced its existing $2.0 billion credit facility with a new $1.5 billion facility. The termination of the prior facility was concurrent with and contingent upon the effectiveness of the new agreement. The new facility reduces the total available revolving credit capacity by $500 million compared to the terminated facility.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary: The filing details the structural terms of the new agreement, including customary negative covenants (limitations on consolidations, mergers, asset sales, liens, and sale-leaseback transactions) and affirmative covenants.
Risks and Contingencies: The agreement defines customary events of default, including:
- Nonpayment of obligations.
- Violation of covenants.
- Breach or default of agreements related to debt equal to or greater than $100 million.
- Certain events of bankruptcy or insolvency.
- Certain judgments equal to or greater than $100 million.
- Change in control of the Company.
Guarantees: All borrowings by U.S. and non-U.S. subsidiaries are guaranteed by the Company.
Important Facts for Investor Verification
- Verify the specific identity of the "certain credit rating agency" required to maintain a long-term debt rating under the new agreement.
- Confirm the utilization status of the new $1.5 billion facility versus the terminated $2.0 billion facility to assess immediate liquidity impact.
- Review the full text of Exhibit 10.1 for specific definitions of "change in control" and grace periods applicable to events of default.
- Check subsequent filings for any drawdowns on the new facility or changes in the Company's credit rating.